| 期刊簡介 | |||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Clinical Journal of the American Society of Nephrology LetPub Score 7.6
50 ratings
Rate
Reputation 8.8 Influence 6.8 Speed 7.0 | ||||||||||||||||||||||||||||
| 期刊簡稱 | CLIN J AM SOC NEPHRO | ||||||||||||||||||||||||||||
| ISSN | 1555-9041 | ||||||||||||||||||||||||||||
| E-ISSN | 1555-905X | ||||||||||||||||||||||||||||
| h-index | 128 | ||||||||||||||||||||||||||||
| CiteScore |
| ||||||||||||||||||||||||||||
| 自引率 (2023-2024) | 4.70%自引率趨勢 | ||||||||||||||||||||||||||||
| 掲載範囲 |
| ||||||||||||||||||||||||||||
| 官方網站 | http://cjasn.asnjournals.org/ | ||||||||||||||||||||||||||||
| 在線稿件提交 | http://mc.manuscriptcentral.com/cjasn | ||||||||||||||||||||||||||||
| 開放訪問 | No | ||||||||||||||||||||||||||||
| 出版商 | American Society of Nephrology | ||||||||||||||||||||||||||||
| 主題領域 | 医学 | ||||||||||||||||||||||||||||
| 出版國/地區 | UNITED STATES | ||||||||||||||||||||||||||||
| 發行頻率 | 隔月刊行 | ||||||||||||||||||||||||||||
| 創刊年 | 2006 | ||||||||||||||||||||||||||||
| 每年文章數 | 166每年文章數趨勢 | ||||||||||||||||||||||||||||
| 黃金OA百分比 | 5.79% | ||||||||||||||||||||||||||||
| Web of Science 四分位 （ 2023-2024） | WOS Quartile: Q1
| ||||||||||||||||||||||||||||
| 索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||||||||||
| 鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1555-9041%5BISSN%5D | ||||||||||||||||||||||||||||
| 平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Ordinary, 3-6 Week(s) | ||||||||||||||||||||||||||||
| 競爭力 * | 來自作者的數據: Difficult | ||||||||||||||||||||||||||||
| 參考鏈接 |
| ||||||||||||||||||||||||||||
| *所有的審稿過程指標，如接受率和審稿速度，僅限於用戶提交的稿件。因此，這些指標可能無法準確反映期刊的競爭力或速度。 | |||||||||||||||||||||||||||||
|
|
| |
| 首頁 上一頁 1 下一頁 末頁 (頁 | |
| [Clinical Journal of the American Society of Nephrology] 的評論 | 撰寫評論 |
| 作者: 宴何 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2024-11-02 18:41:02 評論於 May I ask how much it costs to submit this article?  (0) 讚！ | 宴何  |
| 作者: 香风庆军 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2024-09-09 09:05:21 評論於 Review speed: 2.0 | Submission acceptance rate: 25.0 Experience sharing: In the field of kidney, it is quite challenging to get published in classic journals. One of my submissions had a relatively fast review speed, while several rejections were also received quickly. The fastest rejection was less than 24 hours. It is a reputable journal that does not waste time, so if you are not afraid of trouble, you can give it a try. (0) 讚！ | 香风庆军 |
| 作者: 留云戊子 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2024-03-27 12:56:01 評論於 How have you been doing lately? (0) 讚！ | 留云戊子 |
| 作者: 如影春丝 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2022-11-07 15:19:19 評論於 Did I go directly from being an associate editor to the editor-in-chief in just two days without going through the external review process, and was my submission rejected? (0) 讚！ | 如影春丝 |
| 作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2021-12-30 17:12:06 評論於 A letter is a type of research article published in journals, usually with a shorter length and less research data (0) 讚！ | 维尔娜菲茨杰拉德 |
| 作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2021-12-30 16:42:27 評論於 A research article is the main type of article published in journals, typically longer in length and with a larger amount of research data (0) 讚！ | 维尔娜菲茨杰拉德 |
| 作者: 平原文波 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2021-12-28 18:12:55 評論於 What does research article mean? (0) 讚！ | 平原文波 |
| 作者: 魂魄彦露 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2021-12-28 16:42:35 評論於 What is a letter? (0) 讚！ | 魂魄彦露 |
| 作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2017-07-16 18:54:55 評論於 Lingering here, but already at this critical point in the journal, it is not easy to move up further. More than 4 points, also considered satisfactory (0) 讚！ | 凌霄高洁 |
| 作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2014-08-25 17:34:01 評論於 Submission success rate: 25.0%. Sharing experience: Rejected on the same day, so sad (0) 讚！ | 凌霄高洁 |
| 首頁 上一頁 1 下一頁 末頁 (頁 | |
Contact us
